Ongoing studies:
- The role of selective neck dissection used electively in patients with early oral squamous cell carcinoma (tumour stage T1 and T2) and no clinical evidence of lymph node metastases in the neck (SEND) (10 year follow-up to be completed)
- Can genomics predict dysphagia after head and neck radiotherapy? (GRAD)
Clinical Trials currently in development: